Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
84 JPY | -1.18% | 0.00% | -22.22% |
Business Summary
Number of employees: 25
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drug Discovery
100.0
%
| 81 | 100.0 % | 66 | 100.0 % | -18.47% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| 81 | 100.0 % | 66 | 100.0 % | -18.47% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | - | - | |
President | 76 | 31/07/03 | |
Chief Tech/Sci/R&D Officer | - | - | |
Hisato Oiwa
ADM | Chief Administrative Officer | - | - |
Emiko Nakamura
BRD | Director/Board Member | 45 | 31/07/03 |
Kazumasa Akita
PRN | Corporate Officer/Principal | - | - |
Yoshimi Nakajima
LAW | General Counsel | - | - |
Taro Nishikido
AUD | Comptroller/Controller/Auditor | - | - |
Satoshi Ishimaru
PRN | Corporate Officer/Principal | - | - |
Kazuaki Aoki
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 75 | 30/06/15 | |
President | 76 | 31/07/03 | |
Emiko Nakamura
BRD | Director/Board Member | 45 | 31/07/03 |
Toshiyuki Mori
BRD | Director/Board Member | 56 | 31/05/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 36,511,440 | 33,739,938 ( 92.41 %) | 19,002 ( 0.0520 %) | 92.41 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
RIBOMIC INC. 0.02% | 6,100 | 0.02% | 3,256 $ |
Company contact information
Ribomic, Inc.
Shirokanedai Usui Building, 6/F 3-16-13 Shirokanedai
108-0071, Tokyo
+
http://www.ribomic.comSector
1st Jan change | Capi. | |
---|---|---|
-22.22% | 19.76M | |
+7.52% | 113B | |
+11.38% | 106B | |
-12.64% | 22.22B | |
+0.44% | 22.27B | |
-4.18% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+37.41% | 12.52B | |
-23.95% | 8.34B |
- Stock Market
- Equities
- 4591 Stock
- Company Ribomic Inc.